FDA, CISA warn of vulnerabilities in medical devices used for genetic testing

The U.S. Food and Drug Administration (FDA) and Cybersecurity and Infrastructure Security Agency (CISA) warned on Thursday that vulnerabilities have been found in software from Illumina, a company that produces tools used for genetic analysis.  CISA said if exploited, the bugs would allow an attacker “to take control of the affected product remotely and take […]

The post FDA, CISA warn of vulnerabilities in medical devices used for genetic testing appeared first on The Record by Recorded Future.

briefs cisa cve-2022-1517 cve-2022-1518 cve-2022-1519 devices fda genetic testing government illumina medical medical devices technology testing vulnerabilities vulnerabilities in medical devices